Published in J Am Acad Dermatol on May 01, 1989
Human infections due to Malassezia spp. Clin Microbiol Rev (1992) 1.61
Immunology of diseases associated with Malassezia species. Clin Microbiol Rev (2002) 1.57
Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting. Med J Armed Forces India (2011) 0.77
Yersinia enterocolitica: a panoramic view of a charismatic microorganism. CRC Crit Rev Microbiol (1977) 6.66
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol (2001) 3.92
Biotyping of Aeromonas isolates as a correlate to delineating a species-associated disease spectrum. J Clin Microbiol (1984) 3.71
Bacteremia and endocarditis caused by satelliting streptococci. Am J Clin Pathol (1974) 2.41
Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis (1989) 2.38
Unusual Yersinia enterocolitica isolates not associated with mesenteric lymphadenitis. Appl Microbiol (1974) 2.20
The systems approach to diagnostic microbiology. Crit Rev Microbiol (1981) 2.15
Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool. J Clin Microbiol (1981) 2.10
Sterility of refrigerated injectable collagen syringes after injection of patient. J Am Acad Dermatol (1992) 2.05
Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis. J Infect Dis (1985) 1.92
Phenotypic markers associated with gastrointestinal Aeromonas hydrophila isolates from symptomatic children. J Clin Microbiol (1983) 1.86
Atypical Yersinia enterocolitica: clinical and epidemiological parameters. J Clin Microbiol (1978) 1.85
Microbiologic and clinical evidence supporting the role of Aeromonas caviae as a pediatric enteric pathogen. J Clin Microbiol (1990) 1.74
Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol (1999) 1.67
Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol (1995) 1.65
Isolation of bacillus HB-1 from human clinical sources. Am J Clin Pathol (1973) 1.62
Group D streptococcal bacteremia, with emphasis on the incidence and presentation of infectious due to Streptococcus bovis. N Engl J Med (1973) 1.53
Aeromonas species in clinical microbiology: significance, epidemiology, and speciation. Diagn Microbiol Infect Dis (1983) 1.51
Duration of remission of psoriasis therapies. J Am Acad Dermatol (1999) 1.51
Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome. Arch Dermatol (1997) 1.48
Investigations of the bacteriological factors in clean neurosurgical wounds. Neurosurgery (1994) 1.47
Aeromonas hydrophila diarrhea in a long-term care setting. J Am Geriatr Soc (1990) 1.46
Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med (1978) 1.46
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1987) 1.44
New cutaneous manifestations of systemic diseases. Am Fam Physician (1995) 1.42
Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol (1998) 1.40
A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl) (2000) 1.39
Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol (1998) 1.39
Atopic dermatitis. Lancet (1998) 1.37
The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol (1980) 1.36
Spheroplasts of Haemophilus influenzae induced by cell wall-active antibiotics and their effect upon the interpretation of susceptibility tests. Antimicrob Agents Chemother (1976) 1.30
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol (2013) 1.26
Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol (1975) 1.25
Cytotoxin and enterotoxin production as factors delineating enteropathogenicity of Aeromonas caviae. J Clin Microbiol (1990) 1.24
Biotyping and exoenzyme profiling as an aid in the differentiation of human from bovine group G streptococci. J Clin Microbiol (1984) 1.23
Value of blood agar for primary plating and clinical implication of simultaneous isolation of Aeromonas hydrophila and Aeromonas caviae from a patient with gastroenteritis. J Clin Microbiol (1984) 1.23
Yersinia enterocolitica: recovery and characterization of two unusual isolates from a case of acute enteritis. J Clin Microbiol (1977) 1.22
Cardiobacterium hominis: review of microbiologic and clinical features. Rev Infect Dis (1983) 1.21
Erwinia infections in man. CRC Crit Rev Clin Lab Sci (1973) 1.19
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest (1988) 1.19
Poorly encapsulated Cryptococcus neoformans from patients with AIDS. I: Preliminary observations. AIDS Res (1986) 1.18
Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med (1976) 1.16
Pseudomonas aeruginosa: changes in antibiotic susceptibility, enzymatic activity, and antigenicity among colonial morphotypes. J Clin Microbiol (1982) 1.15
Suicide phenomenon in mesophilic aeromonads as a basis for species identification. J Clin Microbiol (1989) 1.15
Current trends of Yersinia enterocolitica isolates in the New York City area. J Clin Microbiol (1983) 1.14
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 1.12
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol (2000) 1.11
Yersinia enterocolitica: guidelines for serologic diagnosis of human infections. Rev Infect Dis (1983) 1.11
Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City. J Clin Microbiol (1986) 1.08
Metastatic Crohn's disease. J Am Acad Dermatol (1984) 1.07
Diagnosis of pseudoxanthoma elasticum by scar biopsy in patients without characteristic skin lesions. N Engl J Med (1987) 1.07
Rhizopus rhizopodiformis: emerging etiological agent of mucormycosis. J Clin Microbiol (1979) 1.07
Correlation of the suicide phenomenon in Aeromonas species with virulence and enteropathogenicity. J Clin Microbiol (1988) 1.06
Induction of 8-oxo-7,8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells. Photochem Photobiol (1997) 1.06
Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol (2001) 1.05
Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. J Am Acad Dermatol (2001) 1.05
Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient. Am J Med (1981) 1.05
Human infections with Mycobacterium bovis. Am Rev Respir Dis (1974) 1.04
Correlation of proteolytic activity of Pseudomonas aeruginosa with site of isolation. J Clin Microbiol (1980) 1.04
Inhibition of Acanthamoeba species by Pseudomonas aeruginosa: rationale for their selective exclusion in corneal ulcers and contact lens care systems. J Clin Microbiol (1993) 1.04
Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax (1985) 1.03
Intramuscular penicillin administration at birth: prevention of early-onset group B streptococcal disease. Pediatrics (1978) 1.02
Corynebacterium aquaticum urinary tract infection in a neonate, and concepts regarding the role of the organism as a neonatal pathogen. J Clin Microbiol (1989) 1.01
Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage. Free Radic Biol Med (1997) 1.00
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol (2011) 1.00
Trichosporon inkin lung abscesses presenting as a penetrating chest wall mass. Pediatr Infect Dis J (2000) 0.98
Benzo[a]pyrene enhances the formation of 8-hydroxy-2'-deoxyguanosine by ultraviolet A radiation in calf thymus DNA and human epidermoid carcinoma cells. Biochemistry (1998) 0.98
Solitary pulmonary nodules due to nontuberculous mycobacterial infection. Am J Med (1981) 0.98
Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol (2000) 0.97
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. J Eur Acad Dermatol Venereol (2010) 0.97
Yersinia intermedia: temperature-dependent bacteriocin production. J Clin Microbiol (1979) 0.96
DNA structural integrity and base composition affect ultraviolet light-induced oxidative DNA damage. Biochemistry (1998) 0.96
Rapid diagnosis of ocular herpes simplex infections. Br J Ophthalmol (1995) 0.96
Morphological aberrations of nutritionally deficient streptococci: association with pyridoxal (vitamin B6) concentration and potential role in antibiotic resistance. Infect Immun (1983) 0.96
Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol (1993) 0.95
Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radic Biol Med (1999) 0.95
Serum resistance of Yersinia enterocolitica expressed in absence of other virulence markers. Infect Immun (1983) 0.93
Mycobacterium avium complex: significance of isolation from bone marrow culture. J Clin Microbiol (1980) 0.93
Bacteremia and subcutaneous abscess caused by Proteus penneri in a neutropenic host. J Clin Microbiol (1990) 0.93
Calcification of elastic fibers in pseudoxanthoma elasticum. Mt Sinai J Med (1996) 0.93
Entamoeba histolytica: efficacy of microscopic, cultural, and serological techniques for laboratory diagnosis. J Clin Microbiol (1979) 0.92
Comparative studies and laboratory diagnosis of Vibrio vulnificus, an invasive Vibrio sp. J Clin Microbiol (1984) 0.91
Prevalence of unique Yersinia enterocolitica in the area of the Mount Sinai Hospital, New York, N.Y. Contrib Microbiol Immunol (1979) 0.91
Subcutaneous fat necrosis of the newborn with hypercalcemia. J Am Acad Dermatol (1987) 0.91
Capsule-deficient cryptococci in AIDS. Lancet (1985) 0.90
Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotype. Pediatr Dermatol (2000) 0.90
Listeria monocytogenes: another look at the "Cinderella among pathogenic bacteria". Mt Sinai J Med (1977) 0.90
Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis (1998) 0.90
Poorly encapsulated Cryptococcus neoformans from patients with AIDS. II. Correlation of capsule size observed directly in cerebrospinal fluid with that after animal passage. AIDS Res (1986) 0.90
Bordetella bronchiseptica recurrent bacteraemia in the setting of a patient with AIDS and indwelling Broviac catheter. Int J STD AIDS (1992) 0.90
Ultraviolet radiation increases tropoelastin accumulation by a post-transcriptional mechanism in dermal fibroblasts. J Invest Dermatol (1995) 0.90
Cutaneous mycobacteriosis: occurrence and significance in two patients with the acquired immunodeficiency syndrome. Arch Dermatol (1987) 0.89
Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Cancer Res (1986) 0.89
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol (1997) 0.89
Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol (1995) 0.89
Modified Christie-Atkins-Munch-Petersen (CAMP) test for direct identification of hemolytic and nonhemolytic group B streptococci on primary plating. Can J Microbiol (1980) 0.89
Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis (1998) 0.89
Mycobacterium chelonei infection of a Broviac catheter insertion site. Eur J Clin Microbiol Infect Dis (1989) 0.88